jemima
ho
david
l
moy
mahvash
tavassoli
julian
r
naglik
member
epiderm
growth
factor
receptor
famili
erbb
famili
possess
wide
distribut
divers
function
rang
cellular
growth
migrat
apoptosi
though
highli
implic
varieti
cancer
involv
infecti
diseas
less
recognis
grow
bodi
evid
highlight
import
erbb
famili
varieti
infect
role
growth
factor
receptor
along
characterist
surfac
express
continu
intracellular
traffick
make
receptor
famili
ideal
place
exploit
pathogen
herein
review
current
understand
role
erbb
famili
context
infecti
diseas
explor
mechan
govern
pathogen
exploit
system
coevolut
host
pathogen
ensur
host
attempt
maintain
immunolog
homeostasi
invad
organ
look
manipul
host
biolog
benefit
central
role
coevolut
play
host
cell
receptor
recognis
microb
manipul
cellular
respons
pathogen
develop
mechan
subvert
host
cell
receptor
need
erbb
famili
one
group
host
receptor
involv
relationship
erbb
receptor
tyrosin
kinas
famili
consist
four
member
epiderm
growth
factor
receptor
egfr
express
plethora
cell
type
includ
epitheli
endotheli
neuron
glial
bone
adipos
liver
cardiovascular
cell
follow
ligand
bind
activ
oligomeris
erbb
famili
member
occur
erbb
signal
induc
phosphoryl
intracellular
domain
result
activ
sever
major
intracellular
signal
pathway
includ
mitogen
activ
protein
map
kinas
nuclear
factor
kappa
b
nfkb
phosphoinositid
kinas
janu
kinasesign
transduc
activ
transcript
jak
stat
pathway
erbbassoci
signal
pathway
govern
wide
varieti
outcom
includ
cell
surviv
prolifer
cell
deathapoptosi
angiogenesi
adhes
differenti
migrationinvas
major
studi
investig
role
erbb
receptor
infecti
diseas
focu
pathogen
primarili
infect
mucos
surfac
context
erbb
express
epitheli
cell
primari
point
pathogen
contact
play
crucial
role
membran
receptor
erbb
function
localis
make
well
posit
provid
direct
point
contact
entri
host
cell
erbb
famili
member
regularli
endocytos
normal
life
cycl
pathogenerbb
ligat
erbb
receptor
signal
cascad
contribut
cellular
entri
divers
rang
microb
pathogenmedi
hijack
erbb
signal
pathway
also
result
prolong
host
cell
surviv
well
alter
immun
respons
may
turn
enhanc
pathogen
persist
crucial
trend
wide
divers
varieti
microb
evolv
distinct
mechan
exploit
erbb
receptor
highlight
receptor
kinas
famili
critic
factor
initi
mainten
pathogen
infect
erbb
famili
member
utilis
pathogen
attempt
gain
cellular
entri
subvert
immun
respons
manipul
cell
cycl
infect
host
cell
event
support
necessari
pathogen
persist
pathogenmedi
erbbexploit
may
contribut
cellular
transform
oncogenesi
varieti
cancer
use
exist
fdaapprov
drug
target
erbb
receptor
associ
signal
compon
may
offer
potenti
futur
therapi
infect
howev
role
growth
factor
receptor
may
requir
intracellular
organ
depend
host
cell
machineri
selfpropag
hepat
c
viru
hcv
epsteinbarr
viru
ebv
human
papilloma
virus
hpv
pathogen
abl
regul
transit
host
cell
cycl
checkpoint
inde
associ
erbb
receptor
link
cellular
transform
oncogenesi
direct
correl
howev
regul
cell
cycl
oncogenesi
shown
erbb
receptor
clearli
exhibit
divers
import
rang
function
review
attempt
detail
current
understand
role
infect
summaris
tabl
contribut
toward
diseas
influenza
viru
iav
respiratori
syncyti
viru
rsv
coronavirus
respiratori
pathogen
extens
studi
airway
epitheli
cell
regard
replic
cycl
host
respons
elicit
recent
shown
three
virus
abl
utilis
egfr
host
cell
entri
rsv
coronavirus
induc
egfrdepend
macropinocytosi
nonselect
mechan
internalis
larg
bodi
extracellular
materi
iav
induc
lipidraft
cluster
surfac
membran
result
egfr
activ
internalis
viru
egfr
interestingli
lipid
raft
also
import
iav
viral
bud
exit
host
cell
newli
synthesis
structur
iav
protein
hemagglutinin
ha
neuraminidas
na
assembl
cytoplasm
leaflet
lipid
raft
provid
platform
nascent
viral
protein
cluster
form
progeni
viru
bud
given
egfr
localis
lipid
raft
potenti
role
egfr
viral
exit
may
also
exist
see
outstand
question
addit
intestin
bacteri
pathogen
campylobact
jejuni
also
requir
lipidraft
cluster
activ
raftassoci
protein
egfr
plateletderiv
growth
factor
receptor
pdgfr
induct
filopodia
format
bacteri
invas
pathogen
exploit
host
internalis
mechan
larg
microb
appear
adopt
differ
mechan
egfrmedi
host
cell
entri
involv
manipul
epitheli
junction
protein
integr
epithelium
critic
host
defenc
maintain
varieti
protein
locat
interfac
adjac
epitheli
cell
includ
tight
junction
adheren
desmosom
gap
junction
protein
help
maintain
intim
contact
neighbour
cell
cellular
anchorag
polar
well
paracellular
flux
solut
mind
becom
appar
target
protein
may
provid
mean
breach
primari
defenc
barrier
inde
egfr
implic
modul
junction
protein
bacteri
speci
salmonella
enterica
serovar
typhimurium
abl
activ
egfr
induc
express
channelform
tightjunct
protein
result
gut
epithelium
invas
activ
infect
depend
egfr
phosphoryl
evidenc
reduct
bacteri
load
follow
sirnamedi
egfr
downregul
altern
mechan
target
junction
protein
cell
entri
utilis
staphylococcu
aureu
cleavag
occludin
ecadherin
follow
egfr
activ
facilit
transmigr
aureu
cellcel
junction
inhibit
egfr
activ
prevent
aureu
migrat
epitheli
monolay
addit
neisseria
gonorrhoea
induc
egfrdepend
mechan
bcatenin
redistribut
apic
junction
cytoplasm
result
weaken
apic
junction
gonococc
transmigr
across
epithelium
unsurprisingli
enhanc
epitheli
cell
prolifer
improv
barrier
integr
provid
protect
function
pathogen
invas
interestingli
factor
induc
aregdepend
circumvent
apoptosi
induc
prolifer
transform
host
cell
surviv
prolifer
hcmv
alter
egfr
signal
molecul
bypass
cellfat
check
point
enhanc
product
cell
cycl
protein
host
cell
surviv
egfr
activ
promot
latenc
induc
latent
suppress
lytic
gene
express
immun
evas
hpv
induc
egfrdepend
transloc
result
format
bind
complex
requir
viral
entri
campylobact
jejuni
induc
lipidraft
cluster
egfr
activ
host
cell
entri
chlamydia
pneumonia
bacteri
adhesin
directli
bind
egfr
host
cell
entri
escherichia
coli
disrupt
endosom
traffick
result
diminish
surfac
egfr
unconfirm
helicobact
pylori
induc
egfrdepend
bcatenin
nuclear
transloc
signal
host
cell
surviv
dephosphoryl
egfr
inhibit
express
promot
infect
immun
modul
klebsiella
pneumonia
induc
egfr
depend
inhibit
nfkb
transloc
immun
modul
neisseria
gonorrhoea
induc
redistribut
bcatenin
apic
junction
cytoplasm
egfr
activ
host
cell
entri
induc
transloc
apic
surfac
neisseria
meningitidi
recruit
activ
receptor
host
cell
entri
mycobacterium
lepra
directli
bind
receptor
host
cell
entri
mycobacterium
tuberculosi
prevent
proper
macrophag
function
result
enhanc
infect
immun
modul
salmonella
typhimurium
induc
claudin
express
egfr
downstream
jnk
activ
host
cell
entri
shigella
flexneri
induc
product
regul
egfr
traffick
host
cell
surviv
staphylococcu
aureu
cleav
junction
protein
occludin
ecadherin
facilit
transmigr
egfr
activ
requir
host
cell
entri
fungi
candida
albican
egfr
endocytosi
host
cell
entri
regul
erbb
receptor
protect
role
erbb
receptor
infect
would
interest
explor
context
see
outstand
question
second
erbb
famili
member
also
target
pathogen
cellular
entri
mycobacterium
lepra
directli
bind
activ
induc
downstream
signal
bacteri
invas
schwann
cell
trastuzumab
potent
monoclon
antibodi
abrog
vitro
vivo
lepraeinduc
myelin
damag
highlight
crucial
factor
leprosi
diseas
bacterium
neisseria
meningitidi
also
induc
recruit
aggreg
erbb
famili
member
endotheli
cell
membran
directli
beneath
site
bacteri
coloni
format
subsequ
activ
downstream
srcdepend
signal
led
internalis
n
meningitidi
invas
target
cell
addit
fungu
candida
albican
utilis
egfr
induc
endocytosi
invas
epitheli
cell
reduc
sever
oropharang
candidiasi
observ
mice
follow
treatment
dual
kinas
inhibitor
liu
et
al
also
document
activ
vulvovagin
candidiasi
human
anoth
pathogenmedi
mechan
promot
host
cell
entri
may
involv
increas
number
erbb
receptor
cell
surfac
erbb
receptor
spend
major
life
span
surfac
cell
membran
continu
undergo
internalis
part
normal
process
fate
internalis
receptor
import
consequ
cell
potenti
receptor
outcom
follow
endocytosi
includ
recycl
back
surfac
associ
prolifer
transport
cellular
compart
multivesicular
bodi
nucleu
mitochondria
relat
homeostasi
target
degrad
thought
promot
cell
death
pathogen
appear
target
traffick
pathway
benefit
exampl
hcv
induc
upregul
hostderiv
suppress
egfr
recycl
result
enhanc
level
surfac
egfr
egfr
activ
subsequ
viral
endocytosi
occur
via
virusinduc
egfr
hostderiv
protein
bind
addit
erbb
ligand
implic
enhanc
egfr
surfac
express
hcv
infect
n
gonorrhoeaeinduc
upregul
sever
erbb
ligand
also
found
coincid
transloc
egfr
receptor
apic
surfac
follow
infect
disrupt
normal
receptor
distribut
within
polaris
epitheli
cell
led
enhanc
bacteri
invas
upregul
egfrligand
mrna
also
observ
convers
howev
escherichia
colimedi
disrupt
endosom
recycl
lead
reduc
surfac
egfr
transferrin
express
addit
exampl
egfrdepend
mechan
host
cell
entri
includ
chlamydia
pneumonia
recruit
egfr
egfrdepend
format
hpv
type
annexin
heterotetram
facilit
infect
interestingli
malign
tissu
patient
hpvassoci
cancer
often
poorli
express
egfr
understand
connect
hpv
egfr
requir
fulli
appreci
relationship
erbbdepend
hostdirect
internalis
target
barrier
integr
well
erbb
traffick
appear
commonli
use
mechan
cellular
entri
divers
rang
pathogen
develop
distinct
pathogenspecif
mechan
achiev
vari
method
internalis
utilis
egfr
clearli
highlight
import
receptor
signific
point
entri
host
cell
erbbmedi
host
cellular
entri
function
receptor
famili
potenti
benefit
invad
organ
erbb
receptor
potent
mediat
cellular
growth
surviv
unsurprisingli
becom
commonli
exploit
target
purpos
also
associ
human
cytomegaloviru
hcmv
egfr
well
studi
hcmv
employ
multipl
mechan
modul
egfr
signal
propag
benefit
includ
rapid
induct
protein
kinas
b
pkb
alia
akt
activ
protein
kinas
downstream
import
role
cell
cycl
regul
cojohari
et
al
show
use
highli
select
akt
inhibitor
hcmv
infect
result
decreas
viabil
infect
monocyt
uninfect
cell
utilis
primari
isoform
akt
signal
switch
occur
hcmvinfect
cell
allow
use
less
domin
isoform
result
prolong
cell
surviv
past
h
cellfat
check
point
cell
viabil
depend
activ
uninfect
cell
inhibit
predomin
isoform
caus
apoptosi
hcmvinfect
cell
instead
succumb
cell
death
follow
inhibit
furthermor
evid
egfrassoci
promot
antiapoptot
protein
myeloid
leukemia
sequenc
heatshock
protein
well
modul
neg
regul
cell
surviv
phosphatas
tensin
homolog
pten
domaincontain
inositol
also
shown
summari
hcmv
appear
abl
activ
egfr
signal
utilis
altern
signal
molecul
pathway
manipul
egfr
select
prevent
cell
apoptosi
propag
benefit
addit
mechan
modul
cell
cycl
via
erbb
receptor
includ
hcvinduc
cell
surviv
amphiregulin
releas
areg
egfr
ligand
helicobact
pyloriinduc
cell
surviv
hyperprolifer
via
egfr
activ
also
shigella
flexneri
promot
host
cell
surviv
use
phosphatidylinositol
impair
lysosom
degrad
regul
egfr
traffick
well
downstream
signal
mechan
increas
host
infect
cell
surviv
appear
involv
enhanc
growth
stimul
suppress
cell
death
mechan
observ
hcmv
hcv
h
pylori
flexneri
capabl
invad
surviv
within
host
cell
suggest
abil
prolong
host
cell
surviv
specif
evolutionari
target
effect
induc
pathogen
benefit
abil
pathogen
modul
host
immun
respons
long
establish
howev
import
erbb
receptor
context
less
known
number
pathogen
found
manipul
egfr
promot
immun
evas
iav
rhinoviru
rv
capabl
inhibit
interferon
ifn
l
product
critic
antivir
cytokin
airway
egfrdepend
mechan
result
enhanc
viral
titr
suppress
ifnginduc
protein
monocyt
cell
chemokin
also
shown
follow
iav
rv
rsv
infect
virusinduc
egfr
signal
addit
nfkb
primari
transcript
factor
govern
immun
respons
target
klebsiella
pneumonia
infect
bronchial
epitheli
cell
signal
pathway
activ
result
diminish
nuclear
transloc
nfkb
like
result
suppress
activ
nfkb
inflammatori
respons
observ
k
pneumonia
infect
egfr
activ
may
also
involv
airway
remodel
hallmark
featur
chronic
obstruct
pulmonari
diseas
copd
asthma
airway
remodel
refer
structur
modif
airway
tissu
involv
increas
smooth
muscl
mass
subepitheli
fibrosi
mucou
gland
hyperplasia
contribut
airflow
obstruct
impair
lung
function
interestingli
hepat
b
viru
hbv
promot
immun
evas
induc
toler
surfac
egfr
upregul
hbvinfect
intrahepat
regulatori
cell
treg
enhanc
immunosuppress
capac
hbvinfect
mice
exhibit
increas
number
treg
cell
express
immunosuppress
cytokin
interleukin
il
tgfb
addit
enhanc
abil
prevent
cell
prolifer
requir
hbv
clearanc
hcmvinduc
latenc
anoth
interest
tactic
provid
immun
evas
also
govern
egfr
activ
infect
abil
induc
latencyassoci
suppress
lytic
gene
shown
egfr
depend
use
egfrspecif
inhibitor
addit
mycobacterium
tuberculosi
utilis
egfrinduc
signal
pathway
within
macrophag
prevent
proper
antimicrobi
macrophag
respons
result
enhanc
murin
infect
howev
contrast
pathogendriven
function
egfr
contribut
infect
egfrinduc
host
protect
function
also
observ
one
studi
highlight
requir
egfr
macrophag
activ
function
h
pylori
egfrdefici
macrophag
exhibit
impair
helper
th
adapt
respons
result
suppress
h
pyloriinduc
chronic
inflamm
diseas
progress
mice
togeth
studi
highlight
complex
egfr
function
abil
contribut
protect
infect
mechan
immun
modul
highli
divers
pathogenspecif
perhap
emphasis
strength
intric
immun
system
special
microbi
speci
observ
pathogen
abl
augment
cellular
immun
respons
egfr
signal
highlight
import
class
receptor
infect
erbb
receptor
activ
highli
associ
oncogen
transform
sever
cancer
includ
head
neck
squamou
cell
carcinoma
hnscc
lung
colon
cancer
known
result
aberr
erbb
express
signal
aberr
lead
overexpress
constitut
activ
erbb
receptor
overproduc
erbb
receptor
ligand
sheddas
cleav
erbb
precursor
ligand
matur
form
shown
caus
cellular
transform
thu
perhap
unsurpris
sever
cancerinduc
pathogen
found
promot
erbb
activ
evid
cellular
transform
directli
caus
pathogeninduc
erbb
signal
fact
erbb
signal
pathway
implic
number
major
oncogen
viru
infect
exampl
hbv
shown
induc
upregul
express
egfr
gene
protein
strongli
associ
hepatocellular
transform
viru
also
thought
enhanc
mrna
stabil
hbvencod
xprotein
hbx
strongli
associ
hepatocellular
carcinoma
hcc
result
enhanc
hcc
cell
migrat
likewis
hcv
infect
result
enhanc
surfac
egfr
express
egfr
activ
consequ
viral
entri
whilst
patient
exhibit
certain
egfr
polymorph
spontan
clear
hcv
infect
hcvinduc
areg
overexpress
human
hepatoma
cell
contribut
prolong
infectedcel
surviv
cirrhosi
hcc
progress
furthermor
egfr
also
cleav
apoptot
cell
shut
signal
found
significantli
higher
concentr
hcc
patient
plasma
presenc
hcv
hbv
infect
whether
reflect
host
attempt
curtail
aberr
cell
prolifer
mere
byproduct
virusinduc
apoptosi
remain
unclear
consist
increas
solubl
egfr
virusinduc
hcc
may
serv
marker
diseas
hpv
anoth
viru
associ
egfr
oncogenesi
interestingli
case
egfr
express
commonli
low
area
detail
investig
one
explan
exist
hpvposit
egfrneg
malign
could
lie
function
redund
erbb
receptor
well
abil
famili
member
regul
express
inde
sever
studi
highlight
overexpress
receptor
even
depend
hpvposit
cancer
whilst
stindt
et
al
show
hcv
induc
downregul
enhanc
egfr
express
hepatocyt
result
reproduc
follow
suppress
sirna
suggest
function
impact
express
egfr
howev
presenc
hpvposit
egfrposit
malign
also
observ
togeth
exampl
highlight
associ
hpvinduc
cancer
erbb
receptor
though
full
extent
receptor
contribut
diseas
remain
incomplet
understood
oncogen
virus
found
associ
egfr
includ
epsteinbarr
viru
ebv
whose
virusencod
protein
induc
egfr
express
kaposi
sarcomaassoci
herpesviru
kshv
promot
egfr
activ
human
cell
leukaemia
viru
htlv
shown
directli
induc
egfrdepend
cellular
transform
addit
bacteriainduc
egfrdepend
oncogenesi
document
associ
h
pylori
gastric
cancer
highli
acknowledg
studi
suggest
pathogen
remain
strongest
known
risk
factor
stomach
tumorigenesi
earli
clearanc
infect
significantli
lower
risk
malign
support
role
carcinogen
crucial
h
pylori
infect
strongli
link
dysregul
egfr
ligand
andor
transactiv
egfr
review
abil
h
pylori
dephosphoryl
egfr
particularli
interest
pathogeninduc
inactiv
egfr
involv
activ
host
tyrosin
phosphatas
result
suppress
antimicrobi
peptid
human
betadefensin
express
sustain
bacteri
infect
curiou
note
erbbdepend
oncogen
pathogen
mention
herein
capabl
replic
intracellularli
coupl
abil
induc
hyperprolifer
would
interest
investig
role
host
cell
turnov
erbbdepend
pathogen
surviv
sever
virus
hbv
hcv
ebv
hpv
among
other
known
requir
host
machineri
protein
synthesi
subsequ
viral
replic
host
translat
apparatu
found
greater
abund
specif
point
host
cell
cycl
subvers
cell
cycl
common
theme
cycl
arrest
induct
may
occur
howev
effect
either
associ
diseas
remain
unclear
inde
virus
possess
abil
regul
cell
cycl
iav
sar
virus
particularli
associ
oncogenesi
investig
precis
requir
oncogen
pathogen
lead
host
cell
surviv
replic
role
erbb
receptor
context
may
provid
valuabl
insight
develop
effect
cancer
therapi
exist
grow
bodi
evid
support
role
erbb
receptor
famili
critic
regul
pathogen
invas
propag
within
human
host
numer
studi
highlight
pathogenselect
exploit
erbb
receptor
mechan
contribut
host
cell
entri
cell
surviv
augment
host
immun
cancer
figur
key
figur
cellular
localis
regul
mode
internalis
recycl
function
capac
make
erbb
famili
excel
target
pathogen
requir
access
host
cell
order
selfrepl
sever
erbbdepend
pathogen
show
capac
regul
cell
cycl
access
host
machineri
howev
direct
effect
prolong
host
cell
surviv
enhanc
prolifer
remain
undefin
malign
occur
result
infect
suggest
like
factor
involv
drive
cellular
transform
infect
grander
scale
role
host
erbb
receptor
infect
overlook
aspect
diseas
warrant
deeper
consider
date
research
context
focus
predominantli
viral
pathogen
much
less
detail
known
regard
bacteri
fungal
infect
investig
also
skew
toward
promin
egfr
interest
host
receptor
may
warrant
erbb
member
undergo
ligandinduc
internalis
greatli
enhanc
appeal
pathogen
exploit
howev
given
function
redund
erbb
receptor
potenti
regul
express
would
remiss
fulli
investig
role
famili
member
drug
resist
increas
plethora
pathogen
immedi
critic
need
develop
innov
therapi
target
novel
factor
erbb
receptor
associ
signal
pathway
may
possess
potenti
valu
novel
therapeut
target
pathogen
infect
notion
support
recent
studi
valid
efficaci
specif
egfr
inhibitor
erlotinib
conjunct
broadspectrum
tyrosin
kinas
inhibitor
sunitinib
rang
evolutionarili
distinct
viral
pathogen
drug
fda
approv
immunomodulatori
cancer
therapi
would
also
excit
prospect
novel
antimicrobi
drug
howev
toxic
concern
includ
advers
skin
condit
diarrhoea
heart
failur
may
warrant
limit
use
treatment
seriou
infect
egfr
associ
lipidraft
cluster
viral
entri
mechan
lipidraft
aggreg
also
involv
viral
egress
egfr
therefor
play
role
bud
nascent
viral
progeni
enhanc
cell
turnov
barrier
integr
shown
protect
pathogen
invas
factor
erbb
receptor
directli
capabl
induc
potenti
enhanc
protect
role
erbb
receptor
prevent
measur
infect
efficaci
would
current
erbbtarget
therapi
pathogen
infect
human
toxic
resist
drug
observ
cancer
patient
